These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16731642)

  • 1. Allicin in garlic protects against coronary endothelial dysfunction and right heart hypertrophy in pulmonary hypertensive rats.
    Sun X; Ku DD
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2431-8. PubMed ID: 16731642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.
    Sun X; Ku DD
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H801-9. PubMed ID: 18055512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective right, but not left, coronary endothelial dysfunction precedes development of pulmonary hypertension and right heart hypertrophy in rats.
    Sun X; Ku DD
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H758-64. PubMed ID: 16172159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Garlic and its active metabolite allicin produce endothelium- and nitric oxide-dependent relaxation in rat pulmonary arteries.
    Ku DD; Abdel-Razek TT; Dai J; Kim-Park S; Fallon MB; Abrams GA
    Clin Exp Pharmacol Physiol; 2002; 29(1-2):84-91. PubMed ID: 11906464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R; Zeballos GA; Tun H; Gewitz MH
    Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats.
    Kajiya M; Hirota M; Inai Y; Kiyooka T; Morimoto T; Iwasaki T; Endo K; Mohri S; Shimizu J; Yada T; Ogasawara Y; Naruse K; Ohe T; Kajiya F
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2737-44. PubMed ID: 17220192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension.
    Kaur G; Singh N; Samuel SS; Bora HK; Sharma S; Pachauri SD; Dwivedi AK; Siddiqui HH; Hanif K
    Pharm Biol; 2015 Jan; 53(1):147-57. PubMed ID: 25237891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
    Ozturk EI; Uma S
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
    Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
    Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eulophia macrobulbon extract relaxes rat isolated pulmonary artery and protects against monocrotaline-induced pulmonary arterial hypertension.
    Wisutthathum S; Demougeot C; Totoson P; Adthapanyawanich K; Ingkaninan K; Temkitthawon P; Chootip K
    Phytomedicine; 2018 Nov; 50():157-165. PubMed ID: 30466974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.
    Baber SR; Deng W; Master RG; Bunnell BA; Taylor BK; Murthy SN; Hyman AL; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1120-8. PubMed ID: 16980338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
    Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.